ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Bush Names 8 to NCAB.

June 13, 2008

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

Consensus Conference Suggest Research Required For Advances In Pain Control

May 30, 1986

Richard Pazdur’s Comments to ODAC

July 22, 2011

No Cancer Letter For Next Two Weeks

August 19, 1994